A PUBLIC BENEFIT, NON-PROFIT ORGANIZATION
CHOOSE YOUR LANGUAGE      French    German    Italian    Spanish    Portugiese    Japanese    Chinese
Home
     Kennedy's Disease Association, Inc.
     
 P.O. Box 1105, Coarsegold, CA 93614 (U.S.A.)
     (559) 658-5950 email: info@kennedysdisease.org
WHAT'S NEW ON THE SITE

     ABOUT KENNEDY'S DISEASE
   What is KD
   Who Gets KD
   KD Symptoms
   Genetic Counseling/Inheritance
   Common Misdiagnosis
     ABOUT THE KDA
   About the KDA
   Scientific Review Board
   Board of Directors
   Testimonials
   Contact Us
     JOIN THE KDA
     NEWS/RESEARCH
   Current Research
   Medical Articles
 • KDA Conferences
   Published Articles
       about the KDA
   KD Treatments
     HELP THE KDA
   Make a Donation
   Fundraising
   Shopping to Help the KDA
   Make a Pledge
   Hope 5 Campaign
   Inform Others
   Buy a Cookbook
   Others Making a Difference
   Business Contributors
   What's Up For Auction
     DISCUSSIONS/SUPPORT
   Discussion Forums
   Chat
   Chat Transcripts
   Personal KD Stories
   KD Contacts
   Stepping Out of the Shadows
   Memorials
   Coakley's Corner
   General Tips
     OTHER RESOURCES
   List of Doctors
   DNA Test Labs
   Medical Equipment
   Emergency Medical Card
   Medical Dictionary
   Links to Other Resources
     GUESTBOOK
   Sign
   View
Fruit Fly Model 
 

$25,000 Grant Awarded November 2003:  Drosophila melanogaster (fruitfly) model system to investigate the molecular pathogenesis of Spinal and Bulbar Muscular Atrophy

The first ever KDA grant  was awarded to J. Paul Taylor, M.D., Ph.D.,
University of Pennsylvania (previously a Fellow in the Neurogenetics Branch of the National Institute of Neurological Disorders and Stroke (NINDS),at the National Institutes of Health).

Dr. Taylor's proposal involves the use of a Drosophila melanogaster
(fruitfly) model system to investigate the molecular pathogenesis of Spinal
and Bulbar Muscular Atrophy (SBMA, aka:  Kennedy's Disease, Kennedy's Syndrome), a hereditary motor neuron disease.  The study will investigate the possible role that altered transcription may play in this disorder and in particular will examine the possible roles of histone acetylation and specific transcription factors.  These experiments are based on important advances in the field of neurodegenerative disease research which demonstrate that neurodegenerative phenotypes may be faithfully reproduced in fruitfly model systems, and that genetic and pharmacologic manipulation of these models can provide mechanistic and potentially therapeutic insight.

This proposal stands an excellent chance of providing important new
information about mechanisms of pathogenesis in SBMA.  It may also provide information that will aid the development of therapeutics for the treatment of SBMA and similar disorders.

The KDA would like to thank Erik Schweitzer, M.D., Ph.D. (Associate Research Neuroscientist Brain Research Institute, UCLA), Harry T. Orr, Ph.D. (Tulloch Professor of Genetics, Department of Laboratory Medicine and Pathology -- Director, Institute of Human Genetics -- University of Minnesota) and Christopher A. Ross M.D. Ph.D. (Professor of Psychiatry and Neuroscience -- Johns Hopkins University School of Medicine -- Division of Neurobiology, Department of Psychiatry) for their extremely valuable impartial reviews and scoring of the grant proposals.  We would also like to thank our Scientific Review Board -- Dr. Kenneth Fischbeck (NIH/NINDS), Dr. Diane Merry (Thomas Jefferson University) and Dr. Albert La Spada (University of Washington) for
their guidance and participation in the discussions of the grant reviews and
scoring.

We would also like to thank all those who have donated funds to the KDA which has allowed this grant proposal to be funded.  Its with your help that we can get the needed funds to the appropriate researchers to help further Kennedy's Disease research and hopefully bring us to a cure or treatment
 
Update provided June 2004 - Click Here.